Integra LifeSciences pays $211mm for TEI Biosciences
To expand its portfolio of reconstructive surgery and regenerative wound care products, Integra LifeSciences Holdings Corp. is buying regenerative medicine firm TEI Biosciences Inc. for $211mm in cash.
- Medical Devices
- Implantable Devices
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.